Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial
PaperCitations, authors & open-access status
Short-course adjuvant trastuzumab therapy in early stage breast cancer in Finland: Cost-effectiveness and value of information analysis based on the 5-year follow-up results of the FinHer Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 53 citations, 2011 year and diamond oa status.
53
Citations
2011
Year
diamond
OA Status